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Background:  Acute  gastroenteritis  norovirus  (NoV)  in  a country  of  continental  dimensions  like  Brazil  has
resulted  in under-reporting  of  the number  of outbreaks,  as  well  as the  genotypes  associated.
Objectives:  To  demonstrate  the role  of  NoV  in outbreaks  occurring  in  the  State  of Rio  Grande  do  Sul,
Southern  Brazil,  we  determined  its prevalence,  as  well  as the  genotypes  associated,  and evaluated  clinical
and  epidemiological  aspects.
Study  design:  NoV  investigation  was  carried  out in  rotavirus  group  A  negative  stool  samples  from  2265
patients  from  741  outbreaks  that  occurred  in the  State  of Rio  Grande  do Sul,  Brazil,  during  a period  of
eight  years  (2004–2011).  NoV  detection  and  nucleotide  sequencing  for genotype  characterization  was
carried  by using  sets  of primers  targeting  a conservative  Rd-Rp  polymerase  genome  region and  the viral
capsid  gene,  respectively.
Results: NoVs  were  detected  in  817 stool  samples  (36.1%)  and  associated  with  327 outbreaks  (44.1%). NoV
GII.2,  GII.3,  GII.4,  GII.6,  GII.12,  GII.13,  GII.14,  GII.15,  GII.17,  GII.21;  and  GI.1 and  GI.3 were  characterized.
GII.4  was the  most  frequently  detected  (72.3%),  with  ﬁve  variants  identiﬁed  (Asia 2003,  Hunter  2004,
Yerseke  2006a,  Den  Haag  2006b,  New  Orleans  2009).  This  study  describes  the  ﬁrst detection  of  GI.1  and
GII.13  and GII.15  in Brazil  and  demonstrates  NoV  winter-spring  seasonality  in  this  region  of  the  country.
Conclusions:  NoVs  were  responsible  for almost  50%  of  outbreaks,  with about  70% of  them  resulting  from
genotype  GII.4  and  its variants.  The  seasonality  observed  could  help  health  authorities  to  establish  a
system  of  active  surveillance  in order  to  reduce  NoV  impact  especially  in congregate  settings.. BackgroundNoroviruses (NoVs) (genus Norovirus)  belong to the family Cali-
iviridae and possess a single-stranded positive-sense RNA genome
hat encodes three open-reading frames (ORF 1-3) [1]. Genetically
Abbreviations: AG, acute gastroenteritis; NoVs, noroviruses; ORF, open-reading
rame; RVA, rotavirus A; RS, Rio Grande do Sul; EIA, enzyme immunosorbent assay;
AGE, polyacrylamide gel electrophoresis; nt, nucleotide.
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diverse, NoVs are divided into ﬁve genogroups (GI–GV), of which
GI, GII, and GIV have been shown to infect humans [2]. These
genogroups are divided into at least 35 genotypes and the genetic
classiﬁcation is based on phylogenetic analysis of the capsid region
(ORF-2) [2].
The major impact of NoV infections in public health has been
demonstrated by their global distribution, which are primarily
responsible for water- and food-borne outbreaks of acute gastroen-
teritis (AG) worldwide [3–5]. NoVs are transmitted by the fecal–oral
route and most AG outbreaks are described in conﬁned places and
large gatherings, such as cruises, resorts and nursing homes [6–8].
The emergence of new variants of NoV GII.4 is associated with
epidemics of large public health impact. The rapid evolution and
spread of these viruses require frequent studies to determine
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revalence, molecular epidemiology, and geographical distribu-
ion, in order to establish measures to prevent AG outbreaks and
rovide data that could contribute to the development of an effec-
ive vaccine for the control of AG [9–11].
In Brazil, despite studies conducted in different regions demon-
trating the high prevalence and diversity of NoVs circulating
n the country, there is still no active laboratory surveillance
etwork for the diagnosis of these viruses [11–14]. In South-
rn Brazil, only one study has reported NoV GII in Porto Alegre
ity [15], despite the several AG outbreaks with no etiologic
eﬁned whose initial investigation has focused on group A rotavirus
RVA).
. Objectives
This study aimed to associate NoV infection to AG outbreaks
hat occurred in the state of Rio Grande do Sul (RS), Southern
razil, over eight years (2004–2011), providing epidemiological
nd molecular characterization of genotypes and variants respon-
ible for those outbreaks. Clinical characteristics of the AG cases
ere also assessed.
. Study design
.1. Study area
The State of Rio Grande do Sul is the coldest Brazilian state,
ocated between latitudes N – 27◦04′ and S – 33◦45′. The climate
s subtropical and the four seasons are well marked. The mean
emperature varies from 14 to 17 ◦C (winter) and 23 to 25 ◦C (sum-
er) and the rainy season includes the months of September to
ovember. It has about 11 million inhabitants and covers a land
rea of 268,781,896 km [2], comprising 496 municipalities grouped
nto seven mesoregions [16].
able 1
rimers used in the polymerase chain reaction for ampliﬁcation of the genome of human
Primers Sequence (5′-3′)a Orientati
Primers to detection NoVb
Mon431f TGG ACI AGR GGI CCY AAY CA + 
Mon432e TGG ACI CGY GGI CCY AAY CA + 
Mon433f GAA YCT CAT CCA YCT GAA CAT − 
Mon434 e GAA SCG CAT CCA RCG GAA CAT − 
Primers to Classiﬁcation of Genogroupsd
Cap Ae GGC WGT  TCC CAC AGG CTT − 
Cap B2 e TAT GTI GAY CCW GAC AC + 
Cap B1e TAT GTT GAC CCT GAT AC + 
Cap Cf CCT TYC CAK WTC  CCA YGG − 
Cap D3 f TGY CTY ITI CCH CAR GAA TGG + 
Cap D1f TGT CTR STC CCC CAG GAA TG + 
Primers to Classiﬁcation of Genogroups g
G1SKFe CTGCCCGAATTYGTAAATGA + 
G1SKRe CCAACCCARCCATTRTACA − 
G2SKFf CNTGGGAGGGCGATCGCAA + 
G2SKR f CCRCCNGCATRHCCRTTRTACAT − 
Primers to classiﬁcation of NoV GII.h
EVP2Ff GTR CCR CCH ACA GTT GAR TCA + 
EVP2Rf CCG GGC ATA GTR GAY CTR AAG AA − 
a IUPAC code to indicate degenerate positions: I, iosine; R, purine (A/G); Y, pyrimidine 
b Reference: [19].
c Pol, Polimerase.
d Reference: [20].
e Genogroup I.
f Genogroup II.
g Reference: [21].
h Reference: [22].
i Primer positions based on Norwalk (M87661) for NoV GI.
j Primer positions based on Lordsdale (X86557) for NoV GII.ical Virology 61 (2014) 345–352
3.2. Clinical specimens
Stool samples were obtained in the context of AG outbreak mon-
itoring under the Uniﬁed Health System (SUS-Brazil) comprising
a hierarchical network in which samples are provided by spon-
taneous demand from outpatients assisted in different Municipal
Health Centers. These samples, through the Central Laboratory of
the State (LACEN-RS), are forwarded to the Regional Rotavirus Ref-
erence Laboratory, Laboratory of Comparative and Environmental
Virology (RRRC-LVCA) for investigating RVA presence by polyacryl-
amide gel electrophoresis (PAGE) [17] and enzyme immune-assay
(EIA) (Premier Rotaclone, Meridian Bioscience, Inc.; Ridascreen, R-
Biopharm).
3.3. Case deﬁnition and inclusion criteria
For this study, one stool sample of 2265 patients with a neg-
ative diagnosis for RVA from 741 AG outbreaks that occurred in
the period 2004–2011, in 97 out of 496 municipalities of the state,
were selected for NoV investigation. AG outbreaks were charac-
terized by the Surveillance Epidemiologic Service as an increase
in the number of cases above the expected range for the popula-
tion involved in that speciﬁc period following the deﬁnition of the
Brazilian Ministry of Health [18].
To characterize NoV genotypes, 112 samples were selected on a
geographic and temporal distribution, in which 50% of the munic-
ipalities of each mesoregion of State of Rio Grande do Sul were
selected by random drawing in Excel 2010. One  sample of each
outbreak per year was selected afterwards.
3.4. Fecal suspension, RNA extraction, and reverse-transcriptionFecal suspensions were prepared in 10% Tris/HCl/Ca2+ (0.01 M,
pH 7.2). The extraction of viral RNA was performed using the
methodology of the QIAamp Viral RNA Mini Kit (QIAGEN, Valencia,
CA, USA) according to the manufacturer’s instructions.
 norovirus.
on Localization Region Position
RNA Polc B 5093–5112i
RNA Pol B 5093–5112i
RNA Pol B 5285–5305i
RNA Pol B 5285–5305i
VP1 D 6897–6914i
VP1 D 6738–6754i
VP1 D 6738–6754i
VP1 D 6667–6684j
VP1 D 6432–6452j
VP1 D 6342–6451j
VP1 C 5671–5689i
VP1 C 5058–5076i
VP1 C 5401–5423j
VP1 C 5401–5423j
VP1 P2 6381–6403j
VP1 P2 6381–6403j
(C/T); S, C/G; I, A/T/C/G; W,  A/T; K, G/T; H, A/T/C.
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Complementary DNA (cDNA) was synthesized using the High
apacity cDNA Reverse Transcription kit (Applied Biosystems, Fos-
er City, CA, USA) according to the manufacturer’s instructions.
.5. Detection and molecular characterization
Table 1 resume the list of primers used for NoV detection and
haracterization showing their sequences and genome positions
ccording the region target and the genogroup.
For NoV diagnosis, a set of primers for amplifying the partial
egion of the ORF-1 that encodes RNA-dependent RNA polymerase
Rp-Rd) known as Region B was used [19].
For NoV genotype characterization by nucleotide sequencing,
ositive stool samples were processed initially by using a set of
rimers speciﬁc for GI and GII targeting the ORF-2 (region D) [20].
amples that did not amplify in the D region were processed with
he ampliﬁcation of the C region (ORF-2) using primers for GI
nd GII [21]. Samples characterized as GII.4 were processed with
rimers for ampliﬁcation of the region P2 (hypervariable region of
P1) [22]. Amplicon puriﬁcation, nucleotide sequencing, edition,
lignment, and phylogenetic analysis of nucleotide sequences were
erformed according to a previous study [11]. The statistical signif-
cance of phylogenetic trees obtained was estimated using 2000
ootstrap replications.
The nucleotide sequence data reported in this study were sub-
itted to GenBank under the numbers: KJ179659–KJ179807 and
J195431–KJ195435.
.6. Statistical analysis
Statistical analyses were performed using Epi Info 7 [23]. Rates
f NoV positivity and association between the frequency of symp-
oms and seasonality were compared using the chi-square test
ithout correction, and when the number of samples was less than
0, the Fisher exact test was used. For the analysis of the results by
ge group, the chi-square test for linear trend was used. A statistical
igniﬁcance was established at p ≤ 0.05.
. Results
.1. Diagnostic and molecular characterization
NoVs were detected in 36.1% (817/2265) of the samples and
ere associated with 44.1% (327/741) of AG outbreaks, with 33.3%
109/327) of them being reported in 2006 when a higher (Table 2)
etection rate (57.8%; 380/658) of positive cases was  observed.
Twelve genotypes of NoV were characterized circulating in
he State of RS during the studied period. GII.4 (81/112; 72.3%)
as the most frequent, followed by GII.6 (n = 11; 9.8%), GII.3
n = 6; 5.4%), GII.17 (n = 3; 2.7%), GII.12 (n = 2; 1.8%), GII.15 (n = 2;
.8%), GII.2 (n = 2; 1.8%), GII.13 (n = 1; 0.9%), GII.21 (n = 1; 0.9%),
nd GII.14 (n = 1; 0.9%). Two samples were genotyped as GI.1
nd GI.3 (Figs. 2 and 3). The characterization of variants of the
6 GII.4 samples revealed the predominance of Den Haag 2006b
ariant, detected in 47.8% (22/46) of samples, then the variant
ew Orleans 2009 was detected in 41.3% (19/46), Yerseke 2006a
.3% (2/46), Hunter 2004 4.3% (2/46), and Asia 2003 2.2% (1/46).
GII.4 was found in all years of the studied period, with higher
etection in 2006 (37%; 30/81), and in this year occurred the
o-circulation of two variants (Table 2). In the other years, a replace-
ent of GII.4 variants was observed. The genotypes cocirculation of
oV GII was observed in all years, especially in the years 2007, 2008,
nd 2010, when ﬁve different genotypes were detected (Table 2).
A total of 112 out of 327 outbreaks were characterized with
2.3% (81/112) of them being associated with the GII.4 genotype Ta
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Fig. 1. Distribution of monthly per year positive cases and frequency of norovirus that occurred in the state of Rio Grande do Sul from 2004 to 2011.
Table 3
Distribution of norovirus infections according to the seasons over a period of 8 years
(2004–2011).
Season No. of positive samples/studied (%)
Summer 135/504 (26.8)
Fall 86/357 (24.1)
Winter 307/714 (43)
Spring 289/690 (41.9)
S
a
c
(
t
4
b
a
a
Table 4
Frequency detection of norovirus according to the age group, 2004–2011.
Age group in years No. of positive samples/studied (%)
≤1 157/514 (30.5)
>1  ≤ 2 153/421(36.3)
>2 ≤ 5 104/344 (30.2)
>5  ≤ 10 50/166 (30.1)
>10 ≤ 20 52/143 (36.4)
>20 ≤ 50 197/472 (41.7)
>50 94/172 (54.6)
No informations 10/33 (30.3)
T
C
N
B
Statistically signiﬁcant differences between Summer and Spring: p ≤ 0.05; Summer
nd Winter: p ≤ 0.05; Fall and Spring: p ≤ 0.05 and Fall and Winter: p ≤ 0.05. p value:
hi-square test without correction.
data not shown). Table 2 presents the temporal distribution of
hese outbreaks showing also GII.4 variants identiﬁed.
.2. Epidemiological and clinical aspectsMonthly distribution of NoV infection revealed a greater num-
er of cases during the colder months of the year (Fig. 1) and the
nalysis over the years has shown a seasonal pattern (p ≤ 0.05) with
 signiﬁcantly higher detection in spring and winter (Table 3).
able 5
linical signs and symptoms in 932 patients infected and not infected with norovirus (No
Clinical features ≤1 year >1 year ≤ 10 
NoV(+)a (n = 47) NoV(−)b (n = 71) NoV(+)a (n = 1
Presence of mucus in feces 11 (23.4) 25 (35.2) 19 (13.1) 
Presence of blood in feces 1 (2.1) 6 (8.4) 4 (2.7) 
Fever  (≥37.5 ◦C) 20 (42.5) 33 (46.5) 60 (41.4) 
Vomit  35(74.5) 38 (53.5) 104(71.7) 
Abdominal pain 20 (42.5) 39 (54.9) 102(70.3) 
Coryza 14 (29.8) 25 (35.2) 34 (23.4) 
Cough 12 (25.5) 25 (35.2) 36 (24.8) 
Dehydration 1 (2.1) 13 (18.3) 19 (13.1) 
oV, noroviruses.
oldface indicates a p value ≤0.05, Chi-square or Fisher’s exact test, as appropriate.
amples percentages (%) are indicated in brackets.
a Norovirus positive samples.
b Norovirus negative samples.Total 817/2265 (36.1)
Chi-square for linear trend, p ≤ 0.05.
Regarding age groups affected, adults older than 20 years had
a higher rate of NoV infection and the detection rate of NoVs
rose signiﬁcantly with increasing age (p ≤ 0.05) (Table 4). In all
age groups, vomiting was signiﬁcantly more frequent among NoV-
positive subjects (p ≤ 0.05). Additionally, presence of blood and
mucus in feces and cough was signiﬁcantly more frequent in NoV-
negative patients (Table 5).
V), according to age group.
years >10 years Total
45) NoV(−)b (n = 225) NoV(+)a (n = 253) NoV(−)b(n = 191)
47(20.9) 39 (15.4) 28 (14.6) 169
12 (5.3) 1 (0.4) 14(7.3) 38
93 (41.3) 52 (20.5) 50 (26.2) 308
112 (49.8) 149(58.9) 85 (44.5) 523
128 (56.9) 167 (66.0) 114 (59.7) 570
59 (26.2) 22 (8.7) 22 (11.5) 176
45 (20.0) 15 (5.9) 24(12.6) 157
37 (16.4) 49 (19.4) 38 (19.9) 157
J.d.S.R. de Andrade et al. / Journal of Clin
Fig. 2. Phylogenetic tree analysis based on the partial region (D) of the gene encod-
ing the VP1 protein of 57 samples belonging to Norovirus genogroup II (GII).
Phylogenetic tree based on the partial nucleotide sequence (214 bp) of the coding
region for the protein VP1 norovirus GII reconstructed from the Neighbor-Joiningical Virology 61 (2014) 345–352 349
5. Discussion
Several studies conducted in Brazil have demonstrated the
impact of NoV infections in cases of GA from outbreaks and sporadic
cases, including hospitalized children [13,24,25]. A retrospective
study conducted in a nursery in the state of Rio de Janeiro, also
evaluating a long period of time, also made clear the importance
of NoV infections in children up to 4 months old kept indoors [26].
However, this study performed in a period of 8 years shows for the
ﬁrst time in Brazil the importance of NoV outbreaks in the pop-
ulation as a whole in a temperate region, as well as the impact
of the introduction of new variants in a given region. The associ-
ation of NoV to almost half of the AG outbreaks emphasizes the
public health importance of those viruses in the country and the
need to establish a NoV diagnosis network in laboratories around
the country as observed in other countries from Europe or United
States, where this high proportion is also observed [27]. Unfortu-
nately, the fragility of the notiﬁcation system still does not allow
the proper identiﬁcation of the source of each outbreak so it was  not
possible to identify if there were outbreaks of food- or water-borne
or person–person origins.
The diversity of NoVs circulating in the state corroborated the
importance of permanently conducting molecular epidemiological
studies. Here, NoVs GII.13, GII.15, and GI.1 were ﬁrst described in
Latin America. NoV GII.13, with few reports in the literature, has
been associated with outbreaks and hospitalization of children in
different countries [28–30]. The GII.15 genotype has been responsi-
ble for outbreaks in Japan, Turkey, and China [31–33], and GI.1 was
associated with outbreaks and sporadic cases in countries such as
South Korea, India, and Italy [34–36]. Due to the larger number of
outbreaks, a strategy for NoV molecular characterization used in
this study selected one sample/outbreak, not allowing the evalua-
tion of occurrence of different genotypes/outbreaks.
The impact of the circulation of GII.4 in the state of Rio Grande do
Sul was  evident as observed in other Brazilian studies [13,26,37,38],
and worldwide since the mid-1990s [9,10,39]. The association
of ﬁve variants of GII.4 conﬁrms the epidemiological impact of
introducing new NoV variants into a geographic region [9,40].
The variants Asia 2003 and Hunter 2004, detected in 2004,
2005,and 2006, showed a pattern of movement similar to that
which occurred in other countries [41,42], although they have been
detected at low frequency. However, variants of GII.4 characterized
in 2006 (Yerseke 2006a and Den Haah 2006b) accounted for 37%
of all GII.4. These variants have been identiﬁed in many studies
as the cause of outbreaks around the world and are recognized
as pandemic variants [39,43,44]. In this study, Den Haag 2006b
variant was the most frequent, being detected during four years
(2006–2009). Its introductions into the state may explain the high
rate of detection of NoV as well the prevalence of GII.4 in 2006. The
variant Yerseke 2006a was detected only in 2009, in contrast to
some studies that report the Yerseke 2006a variant as prevalent in
some countries during the period 2005–2006, and then replaced by
the Den Haag 2006b variant in 2006–2007 and remained in circu-
lation until the period 2008–2009 [9,43,45]. In 2010 and 2011, the
New Orleans 2009 variant was the only variant detected in the state
of RS. In the United States, this variant was ﬁrst detected in the win-
ter of 2009–2010, and involved a large number of outbreaks caused
by GII.4 in 2010 [22]. The substitution of GII.4 variants observed in
NoV outbreaks exposes the population susceptible to a virus for
which it has poor immunity, explaining the frequent involvement
method with the model Kimura 2-parameter and 2000 bootstrap replicates. The
samples are marked with a black circle. The bootstrap values are indicated in the
phylogenetic tree, values less than 70% are not represented. The bar at the bottom
of  the ﬁgure is proportional to the genetic distance.
350 J.d.S.R. de Andrade et al. / Journal of Clinical Virology 61 (2014) 345–352
Fig. 3. Phylogenetic tree analysis based on the partial region (P2) of the gene encoding the VP1 protein of 45 samples belonging to Norovirus genogroup II genotype 4 (GII.4).
Phylogenetic tree based on partial nucleotide sequence (629 bp) of the coding region of the P2 subdomain of VP1 protein of norovirus GII.4, rebuilt from the Neighbor-Joining
method  with Kimura 2-model parameters and 2000 bootstrap replicates. The samples are marked with a black circle. Bootstrap values are shown in the phylogenetic tree,
valore less than 70% are not represented. The bar at the bottom of the ﬁgure is proportional to the genetic distances.
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f this genotype in AG outbreaks and its high prevalence worldwide
39,43].
In this study, genotype GII.6 was the second-most frequently
etected, corroborating data of its prevalence in the country
11–13], and GII.12, 17, and 21 have also been described recently
n the country [11,26]. Outbreaks caused by other genotypes of
oV GII are also described although in lower frequency [28,29].
he low frequency of NoVs belonging to GI corroborates previ-
us studies that also found a low prevalence of this genogroup
11,26,37]. Nonetheless, other studies have shown that GI NoVs
ould be more involved in outbreaks when compared to GII
7,46].
In addition to an extensive characterization of the virus, this
tudy over 8 years has demonstrated the seasonality of NoV in a
emperate climate region. Although the seasonal pattern of NoVs it
s still controversial [47,48], detection peaks in the driest months
ave been described in other Brazilian studies [13,37] including in
he city of Porto Alegre with a higher NoV detection occurring in
pring [15].
Concerning age groups affected, there was a greater detection of
oV in older age groups, but it is important to remember that this
tudy was conducted using samples previously negative for RVA.
he diversity of the etiologic proﬁle of AG in infants including a
igher rate of infection by other viral agents, such as enteric ade-
oviruses, as well as emerging viruses such as human bocaviruses,
ichi viruses, and parasitic and bacterial etiologies infections could
xplain the lower rate of detection in younger age groups when
ompared to adults [49–51].
Vomiting was the most signiﬁcant clinical manifestation
bserved in individuals infected with NoV, which corroborates pre-
ious research showing that vomiting is particularly associated
ith NoV infections [13,27]. Symptoms such as abdominal pain can
e difﬁcult to detect in children less than 1 year of age, which may
xplain the lower frequency in this age group.
It was demonstrated that bloody and mucous diarrhea was less
requent in the NoV-positive patients, conﬁrming previous studies
nd suggesting the presence of enteropathogenic bacteria among
oV-negative patients, although the diagnosis for these pathogens
as not been available [21,52].
The global analysis results obtained in this 8-year study that
ncluded clinical, epidemiological, and molecular aspects of NoV
emonstrates the role of these viruses in cases of an outbreak of
G, contributing to local information necessary for evaluation in
ase of adoption of norovirus vaccine currently available. The great
iversity of NoV, as well as the emergence of new GII.4 variants
t regular intervals, emphasizes the need of continuous molec-
lar epidemiological surveillance of these viruses in the country
nd the strengthening the surveillance network of the Brazilian
tates and neighboring countries. Due to the high cost of diagno-
is, usually done on a molecular basis, few studies have focused
n the detection and molecular characterization of NoV in Latin
merica [53,54]. Recently, the presence and diversity of NoV was
emonstrated in Paraguayan children [53] with strain similarity
anging from 77% to 99% for the genotypes detected when com-
ared to nucleotide sequences obtained in this study (data not
hown). Additionally, strategies for characterization using differ-
nt regions of the genome do not allow comparative analysis.
n conclusion, there is a need to establish a low-cost diagnostic
ethod that can be used in a network of active surveillance in the
egion.unding
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